These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38486811)

  • 1. The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review.
    Cantor N; Silverman M; Gaudreault A; Hutton B; Brown C; Elton-Marshall T; Imtiaz S; Sikora L; Tanuseputro P; Myran DT
    Lancet Reg Health Am; 2024 Apr; 32():100708. PubMed ID: 38486811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
    Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
    Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State Cannabis Legalization and Psychosis-Related Health Care Utilization.
    Elser H; Humphreys K; Kiang MV; Mehta S; Yoon JH; Faustman WO; Matthay EC
    JAMA Netw Open; 2023 Jan; 6(1):e2252689. PubMed ID: 36696111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.
    Myran DT; Brown CRL; Tanuseputro P
    CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation.
    Friesen EL; Konikoff L; Dickson S; Myran DT
    Drug Alcohol Rev; 2024 May; ():. PubMed ID: 38803128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada.
    Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL
    JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of legal cannabis availability on cannabis use and health outcomes: A systematic review.
    Manthey J; Jacobsen B; Hayer T; Kalke J; López-Pelayo H; Pons-Cabrera MT; Verthein U; Rosenkranz M
    Int J Drug Policy; 2023 Jun; 116():104039. PubMed ID: 37126997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System.
    Shi Y; Liang D
    Addiction; 2020 Oct; 115(10):1890-1899. PubMed ID: 32080937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization.
    Myran DT; Gaudreault A; Pugliese M; Manuel DG; Tanuseputro P
    JAMA Netw Open; 2023 Sep; 6(9):e2331551. PubMed ID: 37672273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cannabinoid poisonings and access to the legal cannabis market: findings from US national poison centre data 2016-2019.
    Klein TA; Dilley JA; Graves JM; Liebelt EL
    Clin Toxicol (Phila); 2022 Sep; 60(9):1024-1028. PubMed ID: 35942512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of cannabis retail outlet availability and neighborhood disadvantage with cannabis use and related risk factors among young adults in Washington State.
    Rhew IC; Guttmannova K; Kilmer JR; Fleming CB; Hultgren BA; Hurvitz PM; Dilley JA; Larimer ME
    Drug Alcohol Depend; 2022 Mar; 232():109332. PubMed ID: 35123361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
    Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M
    Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization.
    Wadsworth E; Driezen P; Chan G; Hall W; Hammond D
    Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544
    [No Abstract]   [Full Text] [Related]  

  • 18. Retail availability and legal purchases of dried flower in Canada post-legalization.
    Wadsworth E; Driezen P; Hammond D
    Drug Alcohol Depend; 2021 Aug; 225():108794. PubMed ID: 34098382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation.
    Fataar F; Driezen P; Owusu-Bempah A; Hammond D
    J Cannabis Res; 2024 Feb; 6(1):5. PubMed ID: 38351142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Policies regulating retail environment to reduce tobacco availability: A scoping review.
    Alebshehy R; Asif Z; Boeckmann M
    Front Public Health; 2023; 11():975065. PubMed ID: 36866095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.